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Highlights: 
 Cross-sectional study to analyze violent suicide attempts in bipolar disorder; 
 30.6% of attempters used a violent suicide method; 
 More men in the group of violent suicide attempters; 
 Association between obesity and violent suicide. 
 
Abstract 
 
BACKGROUND: Suicide is one of the leading causes of death in bipolar disorder (BD); violent suicide attempts 
are associated with the highest level of lethality. We aimed to evaluate factors related to the risk of violent 
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suicide in a large naturalistic sample of patients with BD; in addition, we analyzed the rates of lifetime suicide 
attempts and the variables associated with suicidal behavior. 
METHODS: We recruited 847 patients with BD. Patients were grouped according to whether they had a 
lifetime history of suicide attempts and, among suicide attempters, subjects who had used a violent suicide 
method were compared with those who had attempted suicide with a nonviolent method. Comparisons were 
performed using χ2 tests for categorical variables and ANOVA for continuous variables. Logistic regression 
(LogReg) was used to identify explanatory variables associated with violent suicide attempts (dependent 
variable). 
RESULTS: Two hundred and two patients (24%) had a lifetime history of suicide attempts. Subjects with at  
least one lifetime suicide attempt showed longer duration of illness (22.4 ± 14.1 years vs 19.9 ± 14.2 years: p 
0.028), more lifetime hypomanic episodes (3.3 ± 4.3 vs 2.3 ± 3.1: p 0.001), more lifetime depressive episodes 
(6.0 ± 4.4 vs 4.7 ± 4.1: p < 0.001), higher rates of lifetime psychiatric comorbidities (50.0% vs 41.3%: p 0.029), 
higher rates of lifetime medical comorbidities (58.0% vs 48.9%: p 0.028) and higher rates of reduced HDL 
cholesterol (46.2% vs 36.7%: p 0.030). Among suicide attempters, fifty-two patients (30.6%) attempted 
suicide with a violent method. We found more men in the group of violent suicide attempters than in the 
group of nonviolent suicide attempters (65% vs 28%; p: <0.001). Moreover subjects with previous violent 
attempts showed higher mean values of weight (80.5 ± 18.3 vs 69.4 ± 14.7: p <0.001), body mass index (27.8 
± 5.6 vs 25.2 ± 4.7: p <0.003) and waist circumference (98.7 ±18.5 vs 92.4 ± 14.3: p 0.032). The LogReg analysis 
confirmed the association of violent attempts with male gender (p: <0.001; Phi: 0.35) and higher waist 
circumference (p: <0.001; Cohen’s d: 0.39). 
LIMITATIONS: In our research we analyzed lifetime suicide attempts, but the sample does not include 
completed suicides, meaning that we are unable to test whether the results are generalizable to suicide 
deaths. Moreover, some relevant variables, such as medical comorbidities/metabolic parameters at the time 
of suicide attempts and previous medication, were not collected. Another limitation concerns the 
heterogeneity of recruited patients in terms of clinical characteristics (e.g.: medical conditions, drug 
treatments), with potential confounding factors. 
CONCLUSIONS: The present study confirms the association between male gender and violent suicide and 
suggests a correlation between obesity and the use of violent suicide methods. The relationship between 
obesity and suicidal behaviour is worthy of interest and deserves to be explored by further studies.  
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Manuscript 
 
1. Introduction 
Bipolar disorder (BD) is a recurrent and chronic disease characterized by the occurrence of manic (or 
hypomanic), depressive, or mixed episodes. According to the World Health Organization, BD is one of the 
world’s ten most disabling conditions [1, WHO 2008]. Suicide is one of the leading causes of death in BD: as 
reported by the most recent guidelines [2, Yatham et al., 2018], approximately 6%-7% of identified patients 
with BD dies by suicide, 43% report suicidal ideation, 21% suicide plan and 16% suicide attempt within the 
past year. Existing studies suggest that 13.2%-17.5% of patients with BD with a lifetime history of suicide 
attempt performs them with violent methods, such as hanging, shooting or jumping from heights; these 
subjects, despite representing a minority, need to be precociously recognised, as these methods are 
associated with the highest level of lethality [3, Cassidy, 2011].  
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An extensive literature has deepened socio-demographic, clinical, environmental, genetic and 
neurobiological factors related to violent suicide methods in psychiatric disorders [4, Ludwig et al., 2018]. It 
has been well established that men use violent methods more often than women, both in suicide and suicide 
attempts [5, Bradvik, 2007] [6, Mergl et al., 2015]. Furthermore, higher impulsivity and aggression levels as 
well as substance abuse disorder have been associated with violent suicide [7, Zalsman et al., 2006] [8, Ilgen 
et al., 2010] [9, Zupanc et al., 2013] [10, Sheehan et al., 2015]. A few studies investigated the correlation 
between violent suicide and environmental factors, including seasonality, temperature, relative humidity, 
rainfall, hours of sunshine and pressure. A significant positive correlation was found between violent 
attempts and ambient temperature and number of sunshine hours [11, Lin et al., 2008] [12, Vyssoki et al., 
2014]. Recent research works deepened the relation between violent suicide and serotonin axis, including 
candidate gene studies and gene expression studies. In a candidate gene study with a sample of schizophrenic 
patients, a significant association was found between violent suicide and the genotype frequencies of 
promoter of the serotonin-transporter gene (5HTTLPR) polymorphism [13, Balye et al., 2003]. Other studies 
evaluated differences in the promoter polymorphism of the tryptophane hydroxylase (TPH) between violent 
and nonviolent suicide attempters, with conflicting results [Stefulj et al., 2005] [Stefulj et al., 2006]. In order 
to identify neurobiological factors related to violent suicide, the implication of cytokines in the pathogenesis 
of suicide has been recently investigated. Interleukin-6, measured in cerebrospinal fluid (CSF), peripheral 
blood, and postmortem brain tissue, has shown robust associations with violent suicide and suicide 
completion [16, Gananca et al., 2016]. Furthermore, the relationships between metabolic parameters and 
violent suicide have been extensively studied. A study conducted by Tanskanen and colleagues demonstrated 
that serum total cholesterol concentration was positively related to violent but not nonviolent suicide; the 
same trend could be shown for the concentration of high density lipoprotein cholesterol, but not reaching 
statistical significance [17, Tanskanen et al., 2000]. Conversely, two studies performed by Marcincko and 
colleagues found significantly lower cholesterol serum levels in violent suicide attempters compared with 
suicide attempters using nonviolent methods [18, Marcinko et al., 2004] [19, Marcinko et al., 2005]. A similar 
case-control study looked at women with a history of suicide attempts and compared the serum cholesterol 
concentration between violent suicide attempters and nonviolent suicide attempters: again, a lower 
concentration was predictive of violent methods within this sample of patients [20, Vevera et al., 2003]. Two 
postmortem studies, relevant to the question of fatty acid composition and violent suicide, reported the 
following findings: significantly lower cholesterol levels in the prefrontal cortex of violent suicide attempters, 
significantly higher cholesteryl ester hydrolase (LIPA) expression in violent suicide attempters, a significantly 
lower cholesterol/phospholipid level ratio in violent suicide attempters and increased levels of phospholipids 
in violent suicide attempters when compared with nonviolent suicide attempters [21, Freemantle et al., 
2013] [22, Lalovic et al., 2007]. 
Risk factors for violent suicide, with special reference to BD, were investigated by few studies, mainly 
conducted with small samples and heterogeneous methods. Available data suggest that male gender [23, 
Perroud et al., 2007] [24, Nivoli et al., 2011] [25, Dell’Osso et al., 2017], onset of BD with a hypo/manic 
episode [26, Neves et al., 2008] [27, Schaffer et al., 2016], S allele of the serotonin transporter gene (5-
HTTLPR) polymorphisms [26 Neves et al., 2008] and single nucleotide polymorphisms of the CLOCK and 
TIMELESS genes [28, Pawlak et al., 2015] seem to be correlated with an increased risk of suicide with violent 
methods. A study performed by our research group analyzed the correlation between metabolic syndrome, 
lipid profile and suicide with violent methods in bipolar patients, but no significant differences were found in 
violent suicide attempters compared to nonviolent ones [29, D’Ambrosio et al., 2012].  
The primary goal of this study was to evaluate in a large naturalistic sample of patients with BD potential 
factors related to the risk of suicide with violent methods. In addition, we sought to examine in our sample 
the rates of lifetime suicide attempts and the variables associated with suicidal behavior. 
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 2. Material and methods 
 
2.1 Study design and patients 
Data derive from an independent cross-sectional observational study aimed to analyze course characteristics, 
medical conditions and response to treatments in patients with BD.  
Subjects for this study were recruited from all patients with a principal diagnosis of BD type I, II or Not 
Otherwise Specified (NOS) (DSM-IV-TR, DSM-5) [30, American Psychiatric Association 2000] [31, American 
Psychiatric Association 2013] consecutively admitted to the Department of Neuroscience, University of Turin 
(Italy), from January 2006 to February 2019.  
Potential participants were thoroughly explained aims and study procedures and had to give their written 
consent before participation; exclusion criteria included age <18 and refusal to consent participating in the 
study. The protocol was approved by the local Ethical Committees. 
 
2.2 Assessments and procedures 
All diagnoses were confirmed by means of the Mini-International Neuropsychiatric Interview (MINI) [32, 
Sheehan et al., 1998]. At the study entry, general socio-demographic information and clinical data were 
collected for each subject. Clinical characteristics such as age at onset, duration of illness, number of previous 
manic/depressive episodes, psychiatric comorbidity, psychiatric family history, current medication and 
psychopharmacological treatments were ascertained either from clinical charts or by direct questioning the 
study participants. History of suicide attempt, defined as a selft–destructive behavior with the intention of 
ending one’s life, independently of the resulting damage, [33, O’Carroll et al., 1996] was retrospectively 
assessed for each patient, focusing on the modality of suicidal behavior. According to Stenbacka et al. [34, 
2015], the suicide attempt method was defined violent (hanging, shooting, jumping from heights, moving 
train, cutting, drowning) or nonviolent (poisoning). Individuals who had made more than one attempt were 
classified according to the violence of their most violent attempt. 
All subjects received a medical examination; a specific evaluation of metabolic parameters has been 
conducted for each patient: weight was measured fasting and undressed, height barefoot, waist 
circumference at midway between the inferior margin of the ribs and the superior border of the iliac crest, 
at minimal inspiration. Body mass index (BMI) was calculated as the body weight in kilograms divided by the 
square of the body height in metres. Two blood pressure measurements were obtained by using a mercury 
sphygmomanometer: the first with the subject in a lying position, the second with the subject in a seated 
position at least two minutes after the first measurement. The mean blood pressure of the two 
measurements was used. A blood sample (including cholesterol, glucose, triglycerides and HDL-c) was drawn 
in the morning (7:00 am), when patients were fasting for previous 10 hours. Metabolic syndrome has been 
evaluated using definition of the International Diabetes Federation (IDF) Task Force on Epidemiology and 
Prevention, American Heart Association and National Heart, Lung and Blood Institute [35, Grundy et al., 
2005]: metabolic syndrome was present if three or more of the following five criteria were met: 
 Abdominal obesity: waist circumference ≥ 94 cm in men and ≥ 80 cm in women;  
 High blood pressure: systolic pressure ≥ 130 mmHg and/or diastolic pressure ≥ 85 mmHg or on 
antihypertensive medication; 
 High fasting glucose: ≥ 100 mg/dl or on glucose-lowering medication; 
 Hypertriglyceridemia: ≥ 150 mg/dl or on lipid-lowering medication;  
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 Low HDL-C: < 40 mg/dl in men and < 50 mg/dl in women.  
 
2.3 Statistical analysis 
Socio-demographic and clinical features of the patients were summarized as mean and standard deviation 
(SD) for continuous variables and frequency and percentage for categorical variables. Patients were grouped 
according to whether they had a lifetime history of suicide attempts or they had never attempted suicide in 
their life. Further, patients who had used a violent suicide method were compared with those who had 
attempted suicide with a nonviolent method. 
The normality of data distribution was evaluated by using Shapiro-Wilk and Kolmogorov-Smirnov tests. 
Comparisons were performed using χ2 tests for categorical variables and ANOVA for continuous variables. 
Furthermore, logistic regression (LogReg) was used to identify explanatory variables associated with violent 
suicide attempts (dependent variable). 
The results from every statistical comparison of the treatment groups were presented as 2-sides p values 
rounded to 3 decimal places. The criterion for statistical significance in all comparison was a p value < 0.05. 
All statistical analyses were performed by SPSS software version 22.0. 
 
3. Results 
Eight-hundred fifty-three patients with BD were asked to participate; six refused their consent. Among the 
847 patients recruited, 5 (0.6%) were excluded from the research due to lack of data about lifetime suicide 
attempts. 
Ultimately, we completed the analysis using 842 subjects. The demographic and clinical characteristics of the 
total sample are given in Table 1. The sample is representative for the population of patients with BD: 58.7% 
of the patients were females, the majority of the sample (54.5%) had bipolar II disorder, the mean age at 
onset of BD was 29.3±12.4 years, the mean duration of illness was 20.5±14.2 years. Two hundred and two 
patients (24%) had a lifetime history of suicide attempts; among suicide attempters, 22 subjects (10.9%) had 
made more than one attempt in their life. The demographic and clinical differences between suicide 
attempters and non attempters are summarized in Table 1: subjects with at least one lifetime suicide attempt 
showed longer duration of illness (22.4 ± 14.1 years vs 19.9 ± 14.2 years: p 0.028), more lifetime hypomanic 
episodes (3.3 ± 4.3 vs 2.3 ± 3.1: p 0.001), more lifetime depressive episodes (6.0 ± 4.4 vs 4.7 ± 4.1: p < 0.001), 
higher rates of lifetime psychiatric comorbidities (50.0% vs 41.3%: p 0.029), higher rates of lifetime medical 
comorbidities (58.0% vs 48.9%: p 0.028) and higher rates of reduced HDL cholesterol (46.2% vs 36.7%: p 
0.030). 
The suicide attempters' group was further analyzed according to whether they had employed a violent or a 
nonviolent suicide attempt; within the attempters’ group 32 subjects (15.8%) were excluded due to lack of 
data about the modality of suicidal behavior. The results are shown in Table 2. Fifty-two patients (30.6%) 
attempted suicide with a violent method. Violent suicidal attempts consisted respectively in jumping from 
heights (n=17), hanging (n=13), abdominal knife wounds (n=7), gunshot wounds (n=4), gas poisoning (n=4), 
car accident (n=3), others (n=4). In our sample, nonviolent method was drug overdose (n=118). There was a 
statistically significant difference in sex distribution (p: <0.001), with more men in the group of violent suicide 
attempters than in the group of nonviolent suicide attempters (65% vs 28%; p: <0.001). Moreover, we found 
significant differences within metabolic parameters: subjects with previous violent attempts, in comparison 
to patients with nonviolent attempts, showed higher mean values of weight (80.5 ± 18.3 vs 69.4 ± 14.7: p 
<0.001), BMI (27.8 ± 5.6 vs 25.2 ± 4.7: p <0.003) and waist circumference (98.7 ± 18.5 vs 92.4 ± 14.3: p 0.032). 
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There were no further significant differences within other socio-demographic and clinical characteristics 
between the two groups. The LogReg analysis confirmed the association of violent attempts with male gender 
(p: <0.001; Phi: 0.35) and with higher waist circumference (p: <0.001; Cohen’s d: 0.39). The results of the 
LogReg analysis are described in Table 3; independent variables included were gender, BMI, weight, 
abdominal circumference. The LogReg model was statistically significant, χ2 (4) = 29.590, p <.001. The model 
explained 28.0% (Nagelkerke R2) of the variance in response and correctly classified 71.6% of cases. Since 
the LogReg ruled out weight and BMI as independent risk factors, monovariate analyses have been 
conducted in gender subgroups. In male subgroup no differences emerged between violent and nonviolent 
suicide attempters; in female subgroup there are statistically significant differences between violent and 
nonviolent suicide attempters in terms of higher mean body weight (73,2 kg ± 14,5 vs 65,65 ± 12,9: p=.034) 
and BMI (27,7 ± 4,3 vs 25,1 ± 4,9: p=.047). 
 
4. Discussion 
The main objective of this study was to analyze socio-demographic and clinical factors related to violent 
suicide attempts in a large naturalistic sample of patients with BD; in addition, we analyzed the rates of 
lifetime suicide attempts and the variables associated with suicidal behavior. 
The prevalence of lifetime suicide attempts found in our sample (24%) is consistent with those reported by 
previous studies [36, Tondo et al., 2003] [37, Manchia et al., 2013] [27, Schaffer et al., 2015]. Some clinical 
variables (longer duration of illness, more lifetime hypomanic and depressive episodes, higher rates of 
lifetime psychiatric and medical comorbidities) were showed to be associated with greater likelihood of 
lifetime suicide attempts: these results were expected and confirm the most important studies recently 
carried out on this topic [38, Tidemalm et al., 2014] [27, Schaffer et al., 2015].  Furthermore, a correlation 
emerged between reduced HDL cholesterol and lifetime suicide attempts: to date, two studies reported 
lower serum total cholesterol levels in BD patients with history of suicide attempt [38, Tidemalm et al., 2014] 
[39, Vuksan-Cusa et al., 2009], while no association was identified in a previous Italian study [29, D’Ambrosio 
et al., 2012]. Therefore, our finding is noteworthy and deserve further investigation in future studies. 
In our sample about one-third of patients (30.6%) with history of suicidal behavior used violent methods, 
while previous studies showed lower rates of violent suicide attempts in BD (13.2%-17.5%) [40, Yen et al., 
2008] [41, De Abreu et al., 2012] [29, D’Ambrosio et al., 2012]. There are possible explanations for the lack 
of correspondence between our results and available literature data. Firstly, the sample consists of patients 
with a high severity of illness, as our Department is a tertiary referral center located within the University 
General Hospital. Furthermore, investigations on suicidal behaviors in BD, including the present study, are 
heterogeneous, in terms of characteristics of the samples (e.g.: medications, psychiatric comorbidities), 
instruments used to assess suicidality and definition of violent or nonviolent methods. Comparing the 
subjects according to whether they had employed a violent or a nonviolent suicide method, we found 
significant differences across gender, with more men in the group of violent suicide attempters. Our result is 
consistent with previous studies that have demonstrated that the main differences in suicidal behavior 
between men and women is the method chosen to attempt suicide [23, Perroud et al., 2007] [24, Nivoli et 
al., 2011] [29, D’Ambrosio et al., 2012]. No further differences regarding socio-demographic and 
psychopathological features were found between the two groups. Concerning medical comorbidities and 
metabolic disorders, our results showed higher mean values of weight, BMI and waist circumference in the 
group of violent suicide attempters, while no significant difference was found in terms of serum lipid levels, 
glycemia, blood pressure and metabolic syndrome. The LogReg analysis confirmed also abdominal 
circumference as independent variable associated with violent suicide attempts; results from monovariate 
analyses conducted in gender subgroups showed in female group higher mean body weight and BMI values 
in violent attempters. To our knowledge only one previous study, performed by our research group, with a 
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smaller sample size, specifically evaluated the correlation between violent suicide attempts and metabolic 
parameters in BD: the results did not show any significant difference between violent and nonviolent suicide 
attempters. [29, D’Ambrosio et al., 2012]. The methodological limitations of the present study, discussed in 
the following paragraph, make it difficult to interpret the association between higher BMI/abdominal obesity 
and violent suicide methods: data on metabolic parameters at the time of suicide attempts and previous 
pharmacological treatments would be needed to distinguish whether BMI and waist circumference may 
directly influence the use of violent methods or whether subjects with history of violent attempts are more 
likely to be prescribed medication that leads to weigth gain and abdominal obesity (e.g.: second generation 
antipsychotics). The hypothesis of a causal relationship between obesity and violent suicide methods could 
be explained by the association between obesity and impulsivity. Indeed, impulsive personality traits are 
prevalent characteristics in obese BD patients and some studies suggest that obesity and impulsivity together 
may lead to severe course of illness and worse prognosis [42, Galvez et al., 2014]. Therefore, the relationship 
between obesity and suicidal behaviour is worthy of interest and deserves to be explored by further 
methodologically rigorous studies.  
Our study presents several limitations, mostly due to the cross-sectional design and to the fact that data 
derives from a study aimed to investigate clinical characteristics of BD and not suicidal behavior specifically. 
First, in our research we analyzed lifetime suicide attempts, but the sample does not include completed 
suicides, meaning that we are unable to test whether the results are generalizable to suicide deaths; then 
suicidal intent to die is difficult to ascertain retrospectively and information could be biased. Moreover, some 
patients have missing data about the modality of suicidal attempts and some relevant variables, such as 
medical comorbidities and metabolic parameters at the time of suicide attempts. Furthermore, in our 
analysis the impact of pharmacological treatment on suicidal behavior and on metabolic parameters was not 
evaluated, due to the lack of data on medications prior to study entry. Another limitation concerns the 
heterogeneity of recruited patients in terms of clinical characteristics (e.g.: medical conditions, drug 
treatments), with potential confounding factors. 
Instead, the large sample size is a strength of the study. Furthermore, subjects enrolled for this study were 
representative of “real-world” in and outpatients with BD: this should be considered a point of strength in 
terms of generalizability and external validity.  
 
5. Conclusions 
In conclusion, the present study confirms the association between male gender and violent suicide; 
moreover, our findings suggest a correlation between obesity and the use of violent suicide methods, 
especially in female patients, but further research is awaited to explore and clarify this relationship. 
Considering that suicide is regrettably frequent in patients with BD future studies on this issue could help 
detecting individuals at risk of suicide attempt and take appropriate actions as early as possible. 
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Table 1 Socio-demographic and clinical characteristics of the total sample (n = 842) and differences in socio-demographic and 
clinical characteristics between suicide attempters (n = 202) and non attempters (n = 640). 
 
NOS: Not Otherwise Specified 
BMI: Body Mass Index 
  
Characteristics 
Total sample 
(n = 842) 
Suicide 
attempters 
(n = 202) 
Non-suicide 
attempters 
(n = 640) 
F/2 df p 
Age (years), mean  sd 49.9  15.7 50.8  14.7 49.6  16.0 1.017 1 0.313 
Education (years), mean  sd 11.9  4.2  11.8  4.1 11.9  4.2 0.184 1 0.668 
Sex, n (%) 
Male 
Female 
 
348 (41.3) 
494 (58.7) 
 
77 (38.1) 
125 (61.9) 
 
271 (42.3) 
369 (57.7) 
 
1.130 
 
      1 
 
0.288 
Bipolar disorder, type, n (%) 
Bipolar I 
Bipolar II 
Bipolar NOS 
 
352 (41.8) 
459 (54.5) 
28 (3.3) 
 
73 (36.1) 
123 (60.9) 
6 (3.0) 
 
279 (43.6) 
336 (52.5) 
22 (3.4) 
 
5.072 
 
4 
 
0.280 
Age of onset (years), mean  sd  29.3  12.4 28.4  11.8 29.6  12.6 1.528 1 0.217 
Duration of illness (years), mean  sd 20.5  14.2 22.4  14.1 19.9  14.2 4.858 1 0.028 
Duration of untreated illness (years), mean  sd 13.2  12.5 14.3  13.0 12.9  12.4 1.804 1 0.180 
Manic episodes (number), mean  sd 1.3  2.5 1.0  2.1 1.4  2.6 3.154 1 0.077 
Hypomanic episodes (number), mean  sd 2.6  3.4 3.3  4.3 2.3  3.1 11.965 1 0.001 
Depressive episodes (number), mean  sd 5.0  4.2 6.0  4.4 4.7  4.1 13.741 1 <0.001 
Lifetime psychiatric comorbidities, n (%) 365 (43.3) 101 (50.0) 264 (41.3) 4.787 1 0.029 
Family history of mood disorders, n (%)  483 (57.6) 119 (59.2) 364 (57.1) 0.266 1 0.606 
Family history of suicide, n (%) 11 (6.5) 3 (6.4) 8 (7.7) 0.080 1 0.774 
Lifetime medical comorbidity, n (%) 402 (51.1) 112 (58.0) 290 (48.9) 4.855 1 0.028 
Weight (kg), mean  sd 72.6  16.0  72.6  16.6 72.6  15.8 0.001 1 0.974 
BMI (kg/m2), mean  sd 28.5  5.8 25.8  5.1 29.5  5.2 0.386 1 0.535 
Waist circumference (cm), mean  sd 94.2  16.7 94.6  16.1 94.1  16.9 0.071 1 0.790 
Serum lipid levels (mg/dl), mean  sd 
Cholesterol 
Tryglicerides 
      HDL cholesterol 
 
195.2  44.7 
134.2  77.5 
51.9  16.5 
 
193.5  46.1 
135.3  85.4 
51.2  18.1 
 
195.8  44.2 
133.8  74.7 
52.1  15.9 
 
0.290 
0.046 
0.358 
 
      1 
      1 
1 
 
0.591 
0.829 
0.550 
Glycemia (mg/dl), mean  sd 86.4  22.8 88.1  23.0 85.9  22.8 1.214 1 0.271 
Systolic arterial pressure (mmHg), mean  sd 122.9  12.5 122.1  12.5 123.2  12.5 1.006 1 0.316 
Diastolic arterial pressure (mmHg), mean  sd 79.1  8.8 77.9  8.7 79.4  8.8 3.794 1 0.052 
Metabolic syndrome, n (%) 198 (29.3) 58 (33.1) 140 (28.0) 1.654 1 0.198 
Abdominal obesity, n (%) 259 (49.4) 73 (51.4) 186 (48.7) 0.306 1 0.580 
Low HDL cholesterol, n (%) 256 (39.1) 78 (46.2) 178 (36.7) 4.701 1 0.030 
Elevated blood pressure, n (%) 321 (47.9) 85 (48.6) 236 (47.7) 0.387 1 0.824 
Impaired fasting glucose, n (%) 117 (17.5) 37 (21.5) 80 (16.1) 2.876 1 0.237 
Hypertriglyceridemia, n (%) 194 (29.1) 46 (26.7) 148 (29.9) 1.361 1 0.715 
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Table 2 Differences in socio-demographic and clinical characteristics between violent (n = 52) and nonviolent (n = 118) suicide 
attempters. 
 
 
* remained significant after Bonferroni correction: p<0.0017 
NOS: Not Otherwise Specified 
BMI: Body mass index  
Characteristics 
Violent 
attempt 
(n = 52) 
Nonviolent 
attempt 
(n = 118) 
F/2 df p 
Age (years), mean  sd 49.9  15.9 50.2  14.1 0.062 1 0.831 
Education (years), mean  sd 11.8  3.8 11.5  4.1 0.179 1 0.673 
Sex, n (%) 
Male 
Female 
 
34 (65.4) 
18 (34.6) 
 
33 (28.0) 
85 (72.0) 
 
21.16 
 
      1 
 
<0.001* 
Bipolar disorder, type, n (%) 
Bipolar I 
Bipolar II 
Bipolar NOS 
 
17 (32.7) 
34 (65.4) 
1 (1.9) 
 
44 (37.3) 
70 (59.3) 
4 (3.4) 
 
0.69 
 
2 
 
0.707 
Age of onset (years), mean  sd  28.7  13.7 27.9  11.5 0.138 1 0.711 
Duration of illness (years), mean  sd 21.3  14.3 22.4  13.6 0.222 1 0.638 
Duration of untreated illness (years), mean  sd 14.7  14.3 14.7  12.9 0.001 1 0.976 
Manic episodes (number), mean  sd 0.8  1.5 1.2  2.3 0.839 1 0.361 
Hypomanic episodes (number), mean  sd 3.1  3.8 3.1  4.5 0.001 1 0.994 
Depressive episodes (number), mean  sd 5.7  4.0 6.2  4.8 0.460 1 0.499 
Lifetime psychiatric comorbidity, n (%) 23 (44.2) 56 (47.4) 0.151 1 0.697 
Family history of mood disorders, n (%)  28 (53.8) 71 (60.7) 0.69 1 0.405 
Family history of suicide, n (%) 3 (6.4) 8 (7.7) 0.080 1 0.774 
Current psychopharmacological treatment, n (%) 
Monotherapy 
Combination therapy 
None 
Lithium, n (%) 
Anticonvulsivants, n (%)  
First-generation antipsychotics, n (%)  
Second-generation antipsychotics, n (%) 
Antidepressants, n (%) 
 
6 (11.5) 
45 (88.5) 
1 (1.9) 
31 (59.6) 
27 (51.9) 
8 (15.4) 
30 (57.7) 
19 (36.5) 
 
21 (17.8) 
97 (82.2) 
0 (0) 
76 (65.0) 
53 (44.9) 
7 (5.9) 
60 (50.8) 
48 (40.7) 
 
 
3.240 
 
0.442 
0.771 
4.009 
0.679 
0.259 
 
 
2 
 
1 
1 
1 
1 
1 
 
 
0.198 
 
0.506 
0.399 
0.074 
0.410 
0.611 
Lifetime medical comorbidity, n (%) 32 (61.5) 70 (59.3) 0.044 1 0.083 
Weight (kg), mean  sd 80.5  18.3 69.4  14.7 16.6 1 <0.001* 
BMI (kg/m2), mean  sd 27.8  5.6 25.2  4.7 9.34 1 0.003* 
Waist circumference (cm), mean  sd 98.7  18.5 92.4  14.3 0.968 1 0.032* 
Serum lipid levels (mg/dl), mean  sd 
Cholesterol 
Tryglicerides 
      HDL cholesterol 
 
190.6  49.2 
154.2  95.1 
47.6  15.4 
 
194.6  45.0 
131.6  83.2 
52.0 18.9 
 
0.234 
2.272 
1.955 
 
      1 
      1 
1 
 
0.629 
0.134 
0.164 
Glycemia (mg/dl), mean  sd 89.1  23.8 86.9  23.3 0.296 1 0.587 
Systolic arterial pressure (mmHg), mean  sd 124.1  11.9 120.8  12.4 2.529 1 0.114 
Diastolic arterial pressure (mmHg), mean  sd 78.9  8.8 77.5  8.8 0.958 1 0.327 
Metabolic syndrome, n (%) 20 (35.7) 36 (64.3) 1.13 1 0.288 
Abdominal obesity, n (%) 21 (40.4) 49 (41.5) 1.704 1 0.300 
Low HDL cholesterol, n (%) 19 (36.5) 54 (45.8) 0.605 1 0.437 
Elevated blood pressure, n (%) 27 (51.9) 50 (42.4) 1.006 1 0.316 
Impaired fasting glucose, n (%) 12 (23.1) 20 (16.9) 0.789 1 0.374 
Hypertriglyceridemia, n (%) 13 (25.0) 31 (26.3) 0.124 1 0.724 
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Table 3 Relationship between potential explanatory variables and violent suicide methods: results from the logistic regression 
analysis 
 
Dependent variables B S.E. Wald ORa 95% CI OR p 
Gender (Male) 1.820 0.545 11.147 6.174 (2.121-17.972) 0.001 
Body weight -0.002 0.033 0.004 0.998 (0.935-1.065) 0.948 
Body Mass Index 0.086 0.096 0.807 1.090 (0.903-1.315) 0.369 
Abdominal circumference -0.037 0.018 4.309 0.964 (0.931-0.998) 0.036 
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